Læknablaðið - 15.03.1994, Blaðsíða 27

LÆKNABLAÐIÐ
113
13. Anquist KA, Johnson 0, Ericsson M. Serum
lipoproteins and apolipoproteins A I and A II in male
patients with peripheral arterial insufficiency. Acta
Chir Scand 1982; 148: 675-8.
14. Schroll M. Munck 0. Estimation of peripheral
arteriosclerotic disease by ankle blood pressure
measurements in a population study of 60 year old
mcn and womcn. J Chron Dis 1981; 34: 261-9.
15. Fowkes FGR. Housley E, Gawood EHH, et al.
Edinburgh artery study: prevalence of asymptomatic
and symptomatic peripheral arterial disease in the
general population. Int J Epidemiol 1991; 20: 384-
92.
16. Sigfusson N, Sigvaldason H, Steingrimsdottir L, et
al. Decline in ischaemic heart disease in Iceland and
change in risk factor levels. BMJ 1991; 302: 1371-5.
17. Hale WE. Marks RG, May FE. Moore MT. Stewart
RB. Epidemiology of intermittent claudication:
evaluation of risk factors. Age Ageing 1988; 17: 57-
60.
18. Reunanen A, Takkunen H, Aromaa A. Prevalence of
intermittent claudication and its effect on mortality.
Acta Med Scand 1982; 211: 249-56.
19. Agner E. Natural history of angina pectoris, possible
previous myocardial infarction and intermittent
claudication during the eighth decade. A longitudinal
epidemiologic study. Acta Med Scand 1981; 210:
271-6.
20. Rose GA. The diagnosis of ischaemic heart pain and
intermittent claudication in field surveys. Bull WHO
1962; 27: 645-58.
21. Dormandy J, Mahir M, Ascady G, et al. Fate of the
patient with chronic leg ischaemia. A review article. J
Cardiovasc Surg Torino 1989; 30: 50-7.